Audio Conference: COVID-19's Impact on Lab Industry Testing Volumes and Dynamics - June Update

UBS invites you to listen to the 1 hour audio conference recording, "COVID-19's Impact on Lab Industry Testing Volumes and Dynamics - June Update," to hear UBS Research Analysts and XIFIN Executives discuss the latest impacts in the short and long term, that COVID-19 has had on the laboratory and diagnostic testing industry. 

Key Takeaways:

• Learn the latest on Laboratory and Diagnostic Testing Volume trends as states start reopening businesses and COVID testing capacity ramps
• Learn how the COVID-19 outbreak has impacted diagnostic volumes, mix, and reimbursement for a variety of diagnostic providers (hospital, regional, reference, and national providers)
• Understand how the COVID-19 outbreak has impacted industry dynamics and payor behavior
• Understand the key factors in ramping COVID PCR and Serology testing volumes, preferred platforms/instruments, and capacity expectations for the industry heading into the fall
• Learn from XIFIN's own self-testing experience, including data/results and next steps (an intermittent testing program protocol)

UBS Speakers

• Kevin Caliendo, UBS Healthcare Supply Chain & HCIT Senior Analyst
• Dan Brennan, UBS Life Science Tools & Diagnostics Senior Analyst
• ​Matt Taylor, CFA, UBS US Medical Supplies & Devices
• Whit Mayo, UBS Healthcare Services and Managed Care Analyst

XIFIN Featured Speakers

Lâle White
Executive Chairman & CEO
XIFIN, Inc. 

Kyle Fetter
Executive Vice President & General Manager of Diagnostic Services
XIFIN, Inc.